Tango Therapeutics, Inc. - Common Stock (TNGX)

Tango Therapeutics Inc is a biotechnology company focused on developing innovative therapies for the treatment of cancer

The company specializes in understanding the genetic and biological drivers of cancer, utilizing its expertise in synthetic lethality to create targeted treatments that aim to exploit specific vulnerabilities in cancer cells. Tango Therapeutics employs cutting-edge research and drug discovery techniques to identify and develop novel compounds that can improve patient outcomes, emphasizing precision medicine and personalized treatment approaches in oncology. Through their work, they aim to contribute significantly to the advancement of cancer care and the improvement of therapeutic options available to patients.